InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Uger Robert, Directeur Scientifique. Officer active across 1 company, notably Trillium Therapeutics Inc.. Cumulatively, 6 filings have been logged. Activity tracked since 7 May 2021. The latest transaction was filed on 7 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations6 total
3,646 shares@ US$0.303916.6% of flowCommon SharesSEC:0001062993-21-006419
3,646 shares@ US$0.303916.6% of flowCommon SharesSEC:0001062993-21-006419:0
3,646 shares@ US$0.31516.7% of flowCommon SharesSEC:0001062993-21-005487:0
3,646 shares@ US$0.31516.7% of flowCommon SharesSEC:0001062993-21-005487
3,646 shares@ US$0.31316.7% of flowCommon SharesSEC:0001062993-21-004390:0
3,646 shares@ US$0.31316.7% of flowCommon SharesSEC:0001062993-21-004390
6 of 6 declarations
About Uger Robert
Robert Uger is the Chief Scientific Officer at Trillium Therapeutics Inc. He oversees the company's research and development initiatives. His role is essential in ensuring scientific innovation and the development of new treatments.
